Lyme Nosode Drops 2128

Lyme Nosode Drops

Professional Complementary Health Formulas
Human Otc Drug
NDC 63083-2128

Lyme Nosode Drops 2128 also known as Lyme Nosode Drops is a human otc drug labeled by 'Professional Complementary Health Formulas'. National Drug Code (NDC) number for Lyme Nosode Drops 2128 is 63083-2128. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Lyme Nosode Drops 2128 drug includes Angelica Archangelica Root - 2 [hp_X]/59mL Angelica Pubescens Root - 2 [hp_X]/59mL Arnica Montana Whole - 8 [hp_X]/59mL Babesia Microti - 12 [hp_X]/59mL Borrelia Burgdorferi - 12 [hp_X]/59mL Bovine Type Ii Collagen (tracheal Cartilage) - 3 [hp_X]/59mL Causticum - 6 [hp_X]/59mL Ehrlichia Chaffeensis - 12 [hp_X]/59mL Gambir - 2 [hp_X]/59mL Goldenseal - 5 [hp_X]/59mL and more. The currest status of Lyme Nosode Drops 2128 drug is Active.

Drug Information:

Drug NDC:	63083-2128
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Lyme Nosode Drops 2128
Also known as the trade name. It is the name of the product chosen by the labeler.
Proprietary Name Base:	Lyme Nosode Drops
The base of the Brand/Proprietary name excluding its suffix.
Proprietary Name Suffix:	2128
A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Lyme Nosode Drops
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Professional Complementary Health Formulas
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ANGELICA ARCHANGELICA ROOT - 2 [hp_X]/59mL ANGELICA PUBESCENS ROOT - 2 [hp_X]/59mL ARNICA MONTANA WHOLE - 8 [hp_X]/59mL BABESIA MICROTI - 12 [hp_X]/59mL BORRELIA BURGDORFERI - 12 [hp_X]/59mL BOVINE TYPE II COLLAGEN (TRACHEAL CARTILAGE) - 3 [hp_X]/59mL CAUSTICUM - 6 [hp_X]/59mL EHRLICHIA CHAFFEENSIS - 12 [hp_X]/59mL GAMBIR - 2 [hp_X]/59mL GOLDENSEAL - 5 [hp_X]/59mL Load more... LATIGLUTENASE - 8 [hp_X]/59mL LATRODECTUS MACTANS - 10 [hp_X]/59mL MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE - 2 [hp_X]/59mL MANGANESE - 3 [hp_X]/59mL OXALIC ACID - 8 [hp_X]/59mL PHYTOLACCA AMERICANA ROOT - 4 [hp_X]/59mL POTASSIUM CHLORIDE - 3 [hp_X]/59mL RICKETTSIA AKARI - 12 [hp_X]/59mL TOXICODENDRON PUBESCENS LEAF - 6 [hp_X]/59mL TREPONEMIC SKIN CANKER HUMAN - 12 [hp_X]/59mL YUCCA FILAMENTOSA WHOLE - 3 [hp_X]/59mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	15 Aug, 1984
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	09 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Professional Complementary Health Formulas
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	DTN01M69SN 0MF1EI01KJ O80TY208ZW 1948X6KEG3 0J8NV9V5Q8 76TK29UQEZ DD5FO1WKFU 5ERQ90UTGC 3NJQ5D8S6N ZW3Z11D0JV Load more... 090PL12YZJ XJJ7QA858R HF539G9L3Q 42Z2K6ZL8P 9E7R5L6H31 11E6VI8VEG 660YQ98I10 0M6MOQ3BOU 6IO182RP7A 4ZWP7FWI8W T6VR38UJ9I
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class:	Calculi Dissolution Agent [EPC] Increased Large Intestinal Motility [PE] Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] Inhibition Small Intestine Fluid/Electrolyte Absorption [PE] Magnesium Ion Exchange Activity [MoA] Osmotic Activity [MoA] Osmotic Laxative [EPC] Potassium Compounds [CS] Potassium Salt [EPC] Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
63083-2128-2	59 mL in 1 BOTTLE, DROPPER (63083-2128-2)	15 Aug, 1985	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Lyme Nosode Drops 2128

Lyme Nosode Drops

Liquid
Professional Complementary Health Formulas
NDC: 63083-2128

Purpose:

*claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Product Elements:

Lyme nosode drops 2128 lyme nosode drops angelica archangelica root angelica archangelica root angelica pubescens root angelica pubescens root gambir gambir magnesium phosphate, dibasic trihydrate magnesium cation potassium chloride potassium cation manganese manganese yucca filamentosa whole yucca filamentosa whole bovine type ii collagen (tracheal cartilage) bovine type ii collagen (tracheal cartilage) phytolacca americana root phytolacca americana root goldenseal goldenseal toxicodendron pubescens leaf toxicodendron pubescens leaf causticum causticum latiglutenase latiglutenase oxalic acid oxalic acid arnica montana whole arnica montana whole latrodectus mactans latrodectus mactans borrelia burgdorferi borrelia burgdorferi treponemic skin canker human treponemic skin canker human rickettsia akari rickettsia akari babesia microti babesia microti ehrlichia chaffeensis ehrlichia chaffeensis alcohol water

Indications and Usage:

Indications for the temporary relief of minor aches in the muscles or joints, chills, sweats, fatigue, or nausea.*

Warnings:

Warnings persistent symptoms may be a sign of a serious condition. if symptoms persist or are accompanied by a fever, rash, or persistent headache, consult a doctor. keep out of the reach of children. in case of overdose, get medical help or contact a poison control center right away. if pregnant or breastfeeding, ask a healthcare professional before use. keep out of the reach of children. if pregnant or breastfeeding, ask a healthcare professional before use.

Dosage and Administration:

Directions place drops under tongue 30 minutes before/after meals. adults and children 12 years and over: take 10 to 15 drops once weekly or monthly. if mild symptoms are present, take 10 drops up to 3 times per day. consult a physician for use in children under 12 years of age.

Package Label Principal Display Panel:

Label est 1985 professional formulas complementary health lyme nosode drops homeopathic remedy 2 fl. oz. (59 ml) label image

Further Questions:

Questions professional formulas po box 2034 lake oswego, or 97035

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.